These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 10796259)

  • 1. Umbilical vein injection for management of retained placenta.
    Carroli G; Bergel E
    Cochrane Database Syst Rev; 2000; (2):CD001337. PubMed ID: 10796259
    [No Abstract]   [Full Text] [Related]  

  • 2. Umbilical vein injection for management of retained placenta.
    Carroli G; Bergel E
    Cochrane Database Syst Rev; 2001; (4):CD001337. PubMed ID: 11687109
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Umbilical oxytocin injection for the treatment of retained placentas.
    Weeks AD
    Trop Doct; 2003 Jul; 33(3):162-3. PubMed ID: 12870604
    [No Abstract]   [Full Text] [Related]  

  • 4. Umbilical vein injection of oxytocin for retained placenta.
    Ekele B; Morhason-Bello I
    Lancet; 2010 Jan; 375(9709):98-9. PubMed ID: 20004012
    [No Abstract]   [Full Text] [Related]  

  • 5. Umbilical vein oxytocin for the treatment of retained placenta (Release Study): a double-blind, randomised controlled trial.
    Weeks AD; Alia G; Vernon G; Namayanja A; Gosakan R; Majeed T; Hart A; Jafri H; Nardin J; Carroli G; Fairlie F; Raashid Y; Mirembe F; Alfirevic Z
    Lancet; 2010 Jan; 375(9709):141-7. PubMed ID: 20004013
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intraumbilical oxytocin for the management of retained placenta: a randomized controlled trial.
    Gazvani MR; Luckas MJ; Drakeley AJ; Emery SJ; Alfirevic Z; Walkinshaw SA
    Obstet Gynecol; 1998 Feb; 91(2):203-7. PubMed ID: 9469276
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The retained placenta.
    Weeks AD
    Afr Health Sci; 2001 Aug; 1(1):36-41. PubMed ID: 12789132
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intra-umbilical vein injection and retained placenta: evidence from a collaborative large randomised controlled trial. Grupo Argentino de Estudio de Placenta Retenida.
    Carroli G; Belizan JM; Grant A; Gonzalez L; Campodonico L; Bergel E
    Br J Obstet Gynaecol; 1998 Feb; 105(2):179-85. PubMed ID: 9501783
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy of intra-umbilical oxytocin in the management of retained placenta: a randomized controlled trial.
    Samanta A; Roy SG; Mistri PK; Mitra A; Pal R; Naskar A; Bhattacharya SK; Pal PP; Pande A
    J Obstet Gynaecol Res; 2013 Jan; 39(1):75-82. PubMed ID: 22889466
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Release Trial: a randomised controlled trial of umbilical vein oxytocin versus placebo for the treatment of retained placenta.
    Weeks A; Mirembe F; Alfirevic Z
    BJOG; 2005 Oct; 112(10):1458. PubMed ID: 16167963
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Management of retained placenta by umbilical vein injection.
    Carroli G
    Br J Obstet Gynaecol; 1991 Apr; 98(4):348-50. PubMed ID: 2031892
    [No Abstract]   [Full Text] [Related]  

  • 12. Umbilical vein oxytocin in the management of retained placenta: an alternative to manual removal of placenta?
    Lim PS; Singh S; Lee A; Muhammad Yassin MA
    Arch Gynecol Obstet; 2011 Nov; 284(5):1073-9. PubMed ID: 21136267
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Management of total placental retention with oxytocin injected into the umbilical vein].
    Sepúlveda WH
    Rev Chil Obstet Ginecol; 1991; 56(2):111-3. PubMed ID: 1844606
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effect of oxytocin injection into the umbilical vein for the management of the retained placenta.
    Kristiansen FV; Frost L; Kaspersen P; Møller BR
    Am J Obstet Gynecol; 1987 Apr; 156(4):979-80. PubMed ID: 3555083
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Oxytocin injection into the umbilical vein in women with retained placenta: a questionable method.
    Hauksson A
    Am J Obstet Gynecol; 1986 Nov; 155(5):1140. PubMed ID: 3777062
    [No Abstract]   [Full Text] [Related]  

  • 16. Intraumbilical vein injection of prostaglandin F2 alpha in retained placenta.
    Bider D; Dulitzky M; Goldenberg M; Lipitz S; Mashiach S
    Eur J Obstet Gynecol Reprod Biol; 1996 Jan; 64(1):59-61. PubMed ID: 8801151
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Avoiding manual removal of placenta: evaluation of intra-umbilical injection of uterotonics using the Pipingas technique for management of adherent placenta.
    Rogers MS; Yuen PM; Wong S
    Acta Obstet Gynecol Scand; 2007; 86(1):48-54. PubMed ID: 17230289
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intraumbilical oxytocin for management of retained placenta.
    Makkonen M; Suonio S; Saarikoski S
    Int J Gynaecol Obstet; 1995 Feb; 48(2):169-72. PubMed ID: 7540566
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Is there a place for intra-umbilical oxytocin for the management of retained placenta?
    Sivalingam N; Surinder S
    Med J Malaysia; 2001 Dec; 56(4):451-9. PubMed ID: 12014765
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Umbilical vein administration of oxytocin for the management of retained placenta: is it effective?
    Huber MG; Wildschut HI; Boer K; Kleiverda G; Hoek FJ
    Am J Obstet Gynecol; 1991 May; 164(5 Pt 1):1216-9. PubMed ID: 1709781
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.